Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
J Braun, K Karberg - Exploration of Musculoskeletal Diseases, 2024 - explorationpub.com
Immune checkpoint inhibitors (ICI) such as cytotoxic T-lymphocyte associated protein-4
(CTLA-4), programmed cell death-1 (PD-1), programmed death ligand-1 (PD-L1), and …
(CTLA-4), programmed cell death-1 (PD-1), programmed death ligand-1 (PD-L1), and …